<div id="readability-page-1"><p>Coldstream Capital Management Inc. raised its stake in  H. B. Fuller Company (NYSE:FUL - Free Report) by 712.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor  owned 6,254 shares of the specialty chemicals company's stock after buying an additional 5,484 shares during the period. Coldstream Capital Management Inc.'s holdings in H. B. Fuller were worth $376,000 as of its most recent filing with the SEC.</p><ul><li>Industrial Chemicals: 3 Stocks Poised for Growth in the New Year</li></ul><p>Other large investors have also modified their holdings of the company. Partners Capital Investment Group LLP lifted its stake in  H. B. Fuller by 90.3% during the first quarter. Partners Capital Investment Group LLP now owns 64,901 shares of the specialty chemicals company's stock valued at $3,642,000 after buying an additional 30,805 shares in the last quarter.  Entropy Technologies LP purchased a new position in shares of  H. B. Fuller in the first quarter worth approximately $581,000.  Vanguard Personalized Indexing Management LLC raised its holdings in shares of  H. B. Fuller by 12.2% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 9,904 shares of the specialty chemicals company's stock valued at $596,000 after acquiring an additional 1,077 shares during the period.  QRG Capital Management Inc. lifted its position in shares of  H. B. Fuller by 19.1% in the 2nd quarter. QRG Capital Management Inc. now owns 8,147 shares of the specialty chemicals company's stock valued at $490,000 after acquiring an additional 1,309 shares in the last quarter.  Finally, Quantbot Technologies LP boosted its stake in  H. B. Fuller by 612.4% in the 1st quarter. Quantbot Technologies LP now owns 28,083 shares of the specialty chemicals company's stock worth $1,576,000 after purchasing an additional 24,141 shares during the period. 95.93% of the stock is owned by institutional investors. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several analysts have issued reports on FUL shares. Citigroup raised shares of H. B. Fuller from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their target price for the company from $62.00 to $70.00 in a research note on Wednesday, October 22nd. Seaport Res Ptn raised H. B. Fuller from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, September 26th. Weiss Ratings  restated a &#34;hold (c)&#34; rating on shares of H. B. Fuller in a research report on Monday, November 17th. UBS Group initiated coverage on H. B. Fuller in a research note on Friday, November 21st. They set a &#34;neutral&#34; rating and a $60.00 target price on the stock. Finally, Wall Street Zen lowered shares of H. B. Fuller from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, November 24th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have assigned  a Hold rating and one  has issued  a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $66.20.</p><ul><li>Acuity Brands Lights Up Opportunity In The Industrial Sector </li></ul><p><b>Check Out Our Latest Research Report on H. B. Fuller</b></p><h2>Insider Transactions at H. B. Fuller</h2><p>In other H. B. Fuller news, CFO John J. Corkrean sold 14,222 shares of the stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $60.31, for a total transaction of $857,728.82. Following the transaction, the chief financial officer owned 54,646 shares in the company, valued at $3,295,700.26. This trade represents a 20.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Nathan D. Weaver sold 7,075 shares of H. B. Fuller stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $58.38, for a total transaction of $413,038.50. Following the completion of the transaction, the vice president directly owned 9,441 shares in the company, valued at approximately $551,165.58. This represents a 42.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own  1.99% of the company's stock. </p><h2>H. B. Fuller Price Performance</h2><ul><li>Dividend King H.B. Fuller Rises On Hopes For Rebound</li></ul><p>Shares of FUL opened at $58.28 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.18 and a current ratio of 1.93. The firm has a market cap of $3.15 billion, a PE ratio of 31.50, a PEG ratio of 1.05 and a beta of 1.13. The firm's 50 day moving average price is $58.38 and its 200 day moving average price is $58.61. H. B. Fuller Company has a twelve month low of $47.56 and a twelve month high of $77.77. </p><p>H. B. Fuller (NYSE:FUL - Get Free Report) last posted its earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 EPS for the quarter. The company had revenue of $725.90 million during the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%.  H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. As a group, research analysts expect that  H. B. Fuller Company will post 4.07 EPS for the current fiscal year. </p><h2>H. B. Fuller Dividend Announcement</h2><p>The business also recently declared a quarterly dividend, which was paid on Thursday, October 30th. Stockholders of record on Thursday, October 16th were paid a dividend of $0.235 per share. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Thursday, October 16th. H. B. Fuller's dividend payout ratio  is 50.81%. </p><h2>H. B. Fuller Company Profile</h2> (Free Report)<p>H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.</p><h2>See Also</h2><ul><li>Five stocks we like better than H. B. Fuller</li><li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li><li>Power On: Applied Digital’s First AI Data Center Goes Live</li><li>How to Most Effectively Use the MarketBeat Earnings Screener</li><li>Alphabet: The AI Leader Best Positioned to Dominate 2026</li><li>Top Biotech Stocks: Exploring Innovation Opportunities</li><li>2 Reasons to Load Up on Fiserv, 1 to Stay Away</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in H. B. Fuller Right Now?</h2><p>Before you consider H. B. Fuller, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H. B. Fuller wasn't on the list.</p><p>While H. B. Fuller currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Coldstream Capital Management Inc. increased its stake in H. B. Fuller Company by 712.2% in Q2. Analysts have mixed ratings on FUL shares, with a consensus rating of "Moderate Buy" and a target price of $66.20. Insider transactions include sales by CFO John J. Corkrean and VP Nathan D. Weaver. FUL shares opened at $58.28, with a market cap of $3.15 billion.</p>

H. B. Fuller Company $FUL Position Increased by Coldstream Capital Management Inc.